Eli Lilly shares jumped 15% after a clinical trial of its experimental pill showed it helped patients with Type 2 diabetes lose weight at levels comparable to leading injectable medications like ...

Some drugs initially approved to treat Type 2 diabetes are now being used for cosmetic weight loss. WSJ’s Daniela Hernandez ... to hitting the market. Eli Lilly said its experimental pill ...

The market for weight-loss drugs could see new entrants among existing biotech firms, with several drug candidates likely to be approved ... s obesity market will grow, particularly in China ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain dosages ... is a once-daily pill that, if approved, could be "readily ...

WASHINGTON (TNND) — Patients taking Eli Lilly’s drug ... more weight loss than semaglutide, which is the active ingredient in Wegovy and Ozempic. Researchers have said that all the approved ...

Eli Lilly, the drugmaker behind the blockbuster weight loss drug ... never been approved by the FDA. "Fella even tells patients that its untested oral drug is better than Lilly's approved ...

(Reuters) -Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such ... known as GLP-1 agonists approved to prevent major ...

April 17 (UPI) --People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following ... a new option and, if approved, could be readily ...